http://orcid.org/0000-0003-2270-6170
References
- Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet. 2017:391(10116):31822–31826.
- HbVar Database (http://globin.cse.psu.edu/hbvar/menu.html).
- Shang X, Peng Z, Ye Y, et al. Rapid targeted next-generation sequencing platform for molecular screening and clinical genotyping in subjects with hemoglobinopathies. EBioMedicine. 2017;23:150–159.
- Piel FB, Weatherall DJ. The α-thalassemias. N Engl J Med. 2014;371(20):1908–1916.
- Blattner A, Brunner-Agten S, Ludin K, et al. Detection of germline rearrangements in patients with α- and β-thalassemia using high resolution array CGH. Blood Cells Mol Dis. 2013;51(1):39–47.
- Wang Y, Liu C, Zhang L, et al. Identification of a novel 44.6-kb deletion causing α0-thalassemia in southern China. Int J Lab Hematol. 2017;39(4):e94–e97.
- Xu XM, Zhou YQ, Luo GX, et al. The prevalence and spectrum of α- and β-thalassemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol. 2004;57(5):517–522.
- Xiong F, Sun M, Zhang X, et al. Molecular epidemiological survey of haemoglobinopathies in Guangxi Zhuang Autonomous Region of southern China. Clin Genet. 2010;78(2):139–148.
- Xiao J, Zhang L, Wang J, et al. Rearrangement structure-independent strategy of CNV breakpoint analysis. Mol Genet Genomics. 2014;289(5):755–763.
- Yu LH, Liu D, Cai R, et al. Changes in hematological parameters in α-thalassemia individuals co-inherited with erythroid Krüppel-like factor mutations. Clin Genet. 2015;88(1):56–61.
- Xue Y, Ankala A, Wilcox WR, et al. Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing. Genet Med. 2015;17(6):444–451.